Relevant Data

Flavouring Substances Approved by European Union:

  • Salicylaldehyde [show]

General Information

MaintermSALICYLALDEHYDE
Doc TypeASP
CAS Reg.No.(or other ID)90-02-8
Regnum 172.515

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID6998
IUPAC Name2-hydroxybenzaldehyde
InChIInChI=1S/C7H6O2/c8-5-6-3-1-2-4-7(6)9/h1-5,9H
InChI KeySMQUZDBALVYZAC-UHFFFAOYSA-N
Canonical SMILESC1=CC=C(C(=C1)C=O)O
Molecular FormulaC7H6O2
Wikipediasalicylaldehyde

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight122.123
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Complexity101.0
CACTVS Substructure Key Fingerprint A A A D c Y B g M A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D A S g m A I w B o A A A g C I A i h S g A A C A A A k I A A I i A E G C M g I J j a C F R K A c U A k 4 B E I m Y e I y C C O A A A A A A A I A A A A A A A A A B A A A A A A A A A A A A = =
Topological Polar Surface Area37.3
Monoisotopic Mass122.037
Exact Mass122.037
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count9
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


Food Additives Biosynthesis/Degradation


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9344
Human Intestinal AbsorptionHIA+1.0000
Caco-2 PermeabilityCaco2+0.9351
P-glycoprotein SubstrateNon-substrate0.8033
P-glycoprotein InhibitorNon-inhibitor0.9458
Non-inhibitor0.9855
Renal Organic Cation TransporterNon-inhibitor0.8808
Distribution
Subcellular localizationMitochondria0.9067
Metabolism
CYP450 2C9 SubstrateNon-substrate0.7932
CYP450 2D6 SubstrateNon-substrate0.8793
CYP450 3A4 SubstrateNon-substrate0.7523
CYP450 1A2 InhibitorNon-inhibitor0.6301
CYP450 2C9 InhibitorNon-inhibitor0.9801
CYP450 2D6 InhibitorNon-inhibitor0.9552
CYP450 2C19 InhibitorNon-inhibitor0.6464
CYP450 3A4 InhibitorNon-inhibitor0.9503
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.8545
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9110
Non-inhibitor0.9747
AMES ToxicityNon AMES toxic0.9133
CarcinogensNon-carcinogens0.8136
Fish ToxicityHigh FHMT0.7790
Tetrahymena Pyriformis ToxicityHigh TPT0.9663
Honey Bee ToxicityHigh HBT0.7680
BiodegradationReady biodegradable0.8515
Acute Oral ToxicityIII0.8407
Carcinogenicity (Three-class)Non-required0.6665

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-0.7978LogS
Caco-2 Permeability1.9293LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.3639LD50, mol/kg
Fish Toxicity0.4870pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.3241pIGC50, ug/L

From admetSAR


Toxicity Profile

Route of Exposure
Mechanism of Toxicity
Metabolism
Toxicity Values
Lethal Dose
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk Level
Health Effects
Treatment
Reference

From T3DB


Taxonomic Classification

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds
SubclassCarbonyl compounds
Intermediate Tree NodesAldehydes - Aryl-aldehydes - Benzaldehydes
Direct ParentHydroxybenzaldehydes
Alternative Parents
Molecular FrameworkAromatic homomonocyclic compounds
SubstituentsHydroxybenzaldehyde - Benzoyl - 1-hydroxy-4-unsubstituted benzenoid - 1-hydroxy-2-unsubstituted benzenoid - Phenol - Benzenoid - Monocyclic benzene moiety - Vinylogous acid - Organic oxide - Hydrocarbon derivative - Aromatic homomonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as hydroxybenzaldehydes. These are organic aromatic compounds containing a benzene ring carrying an aldehyde group and a hydroxyl group.

From ClassyFire


Targets

General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
Gene Name:
ESR1
Uniprot ID:
P03372
Molecular Weight:
66215.45 Da
References
  1. Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]

From T3DB